Celltrion Healthcare Reports Real-World Results Demonstrated Interchangeability of Rituximab Biosimilar
April 12, 2023
Celltrion Healthcare’s Vegzelma (biosimilar, bevacizumab) Receives the Health Canada’s Approval for the Treatment of Cancer
January 19, 2023
Celltrion Healthcare’s Vegzelma (biosimilar, bevacizumab) Receives the EC’s Approval for the Treatment of Cancers
August 18, 2022
Celltrion Healthcare Receives CHMP Positive Opinion of CT-P16 (biosimilar, bevacizumab) as 1L Treatment of Non-Squamous Non-Small...
June 27, 2022
Insights+ Key Biosimilars Events of March 2022
April 7, 2022
Celltrion Healthcare to Supply Remsima to the Brazilian Federal Government
March 24, 2022
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.